<!DOCTYPE html>
<html lang="en">
<head>
  
  
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    
    
    <link rel="canonical" href="https://jzpero.github.io/mednotes/Obstetric%20Medicine/VTE%20in%20Pregnancy/">
    <link rel="shortcut icon" href="../../img/favicon.ico">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=0" />
    <title>VTE in Pregnancy - MedNotes</title>
    <link href="../../css/bootstrap-3.3.7.min.css" rel="stylesheet">
    <link href="../../css/font-awesome-4.7.0.css" rel="stylesheet">
    <link href="../../css/base.css" rel="stylesheet">
    <link rel="stylesheet" href="../../css/highlight.css">
    <!-- HTML5 shim and Respond.js IE8 support of HTML5 elements and media queries -->
    <!--[if lt IE 9]>
        <script src="https://oss.maxcdn.com/libs/html5shiv/3.7.0/html5shiv.js"></script>
        <script src="https://oss.maxcdn.com/libs/respond.js/1.3.0/respond.min.js"></script>
    <![endif]-->

    <script src="../../js/jquery-3.2.1.min.js"></script>
    <script src="../../js/bootstrap-3.3.7.min.js"></script>
    <script src="../../js/highlight.pack.js"></script>
    
    <base target="_top">
    <script>
      var base_url = '../..';
      var is_top_frame = false;
        
        var pageToc = [
          {title: "VTE in Pregnancy", url: "#_top", children: [
          ]},
          {title: "Diagnosis of VTE", url: "#diagnosis-of-vte", children: [
              {title: "ARTEMIS / Pregnancy-Adapted YEARS Algorithm", url: "#artemis-pregnancy-adapted-years-algorithm" },
              {title: "Imaging Modalities", url: "#imaging-modalities" },
              {title: "Radiation Counselling", url: "#radiation-counselling" },
          ]},
          {title: "Management of Acute VTE in Pregnancy", url: "#management-of-acute-vte-in-pregnancy", children: [
              {title: "Other Treatments", url: "#other-treatments" },
          ]},
          {title: "Management of VTE Peri-Partum", url: "#management-of-vte-peri-partum", children: [
          ]},
          {title: "Anticoagulants and Breast-Feeding", url: "#anticoagulants-and-breast-feeding", children: [
          ]},
          {title: "VTE prophylaxis in pregnancy", url: "#vte-prophylaxis-in-pregnancy", children: [
          ]},
        ];

    </script>
    <script src="../../js/base.js"></script> 
</head>

<body>
<script>
if (is_top_frame) { $('body').addClass('wm-top-page'); }
</script>



<div class="container-fluid wm-page-content">
  <a name="_top"></a>
    

    
    
      
    

  <div class="row wm-article-nav-buttons" role="navigation" aria-label="navigation">
    
    <div class="wm-article-nav pull-right">
      <a href="../../Oncology/CAR-T%20Recipients%20in%20the%20ICU/" class="btn btn-xs btn-default pull-right">
        Next
        <i class="fa fa-chevron-right" aria-hidden="true"></i>
      </a>
      <a href="../../Oncology/CAR-T%20Recipients%20in%20the%20ICU/" class="btn btn-xs btn-link">
        CAR T Recipients in the ICU
      </a>
    </div>
    
    <div class="wm-article-nav">
      <a href="../Thyroid%20Disease%20in%20Pregnancy/" class="btn btn-xs btn-default pull-left">
        <i class="fa fa-chevron-left" aria-hidden="true"></i>
        Previous</a><a href="../Thyroid%20Disease%20in%20Pregnancy/" class="btn btn-xs btn-link">
        Thyroid Disease in Pregnancy
      </a>
    </div>
    
  </div>

    

    <h1 id="vte-in-pregnancy">VTE in Pregnancy</h1>
<ul>
<li>Pregnancy increases the risk of VTE (highest risk in 3rd trimester and in the first 6 weeks postpartum)</li>
<li>DVT<ul>
<li>80% in the left leg (due to left iliac compression)</li>
<li>60% in the iliofemoral vein. Tends to present with back/buttock/thigh pain as opposed to calf pain.</li>
</ul>
</li>
<li>PE<ul>
<li>difficult to clinically diagnose as dyspnea and tachycardia can be normal in pregnancy</li>
</ul>
</li>
</ul>
<h1 id="diagnosis-of-vte">Diagnosis of VTE</h1>
<p><img alt="" src="../_attachments/Pasted%20image%2020230122143232.png" /><img alt="" src="../_attachments/Pasted%20image%2020230122143243.png" /></p>
<h2 id="artemis-pregnancy-adapted-years-algorithm">ARTEMIS / Pregnancy-Adapted YEARS Algorithm</h2>
<p>This was a study published in NEJM by van der Pol et al. in 2019 that examined a strategy using pregnancy-adapted YEARS in the diagnosis of PE in pregnant women.</p>
<p>Population: Adult women with chest pain or dyspnea presenting to hospital.
Intervention: YEARS criteria (s/s of DVT, hemoptysis, and PE as the most likely Dx), combined with the D-dimer (&lt;500 or &lt;1000).</p>
<ul>
<li>Low pretest probability: 0/3 YEARS, D-dimer &lt;1000; effectively excluded PE</li>
<li>Higher pretest probability: 1+ YEARS, D-dimer &lt;500</li>
</ul>
<p>Conclusion: in a low PTP setting (low D-dimer and 0 YEARS), CTPE is not required to rule out PE in pregnant women.</p>
<p>This study is polarizing and a single study; not guideline based yet. <em>Therefore for the RCE, do not follow this study.</em></p>
<h2 id="imaging-modalities">Imaging Modalities</h2>
<ul>
<li>Doppler leg ultrasound<ul>
<li>91% sensitivity, NPV 99%</li>
<li>however, cannot rule out DVT with a single ultrasound</li>
<li>need to ensure visualisation of the proximal veins (iliac, femoral) to the popliteal veins</li>
</ul>
</li>
<li>V/Q vs CTPA<ul>
<li><strong>V/Q scan is first-line according to SOGC/Thrombosis Canada/ACCP</strong></li>
<li>V/Q has less radiation for the mother than CTPA (risk of breast cancer), but slightly greater risk of radiation to the fetus (childhood cancer)</li>
</ul>
</li>
<li>No imaging?<ul>
<li>For now, D-dimer and clinical pretest probability (Well's/YEARS) is NOT recommended for diagnosis if pregnancy. Pregnant women SHOULD undergo diagnostic imaging.</li>
</ul>
</li>
</ul>
<h2 id="radiation-counselling">Radiation Counselling</h2>
<ul>
<li>1 rad = 10 mGy = 10 mSv</li>
<li>10 rads is the required dose for teratogenicity or miscarriage</li>
<li>The acceptable upper limit in pregnancy is <strong>&lt;5 rad</strong></li>
<li>Maternal radiation<ul>
<li>CTPA &lt;0.5 rad</li>
<li>VQ 0.007-0.03 rad</li>
<li>CXR 0.005 rad</li>
</ul>
</li>
</ul>
<p><img alt="" src="../_attachments/Pasted%20image%2020230122144546.png" /></p>
<h1 id="management-of-acute-vte-in-pregnancy">Management of Acute VTE in Pregnancy</h1>
<p><strong>Duration:</strong> minimum 3 months including 6 weeks post-partum
<strong>Drug:</strong> LMWH or UFH
<strong>Considerations:</strong></p>
<ul>
<li>weight based dosing</li>
<li>once or twice daily dosing</li>
<li>Xa level monitoring? (not routinely recommended)</li>
<li>risk of bleeding and HIT</li>
</ul>
<h2 id="other-treatments">Other Treatments</h2>
<ul>
<li>Warfarin is contraindicated in pregnancy<ul>
<li>first trimester: warfarin embropathy (mid-facial and limb hypoplasia and stippledbone)</li>
<li>second-third trimesters: neurologic abnl, microcephaly, optic atropy, neonatal haemorrhage</li>
</ul>
</li>
<li>DOACs are not recommended in pregnant or breastfeeding women</li>
<li>tPA only for life threatening and hemodynamically unstable</li>
<li>HIT: fondaparinux, consult hematology</li>
<li>IVC filter: same indications as outside of pregnancy. Consider use if the VTe is newly diagnosed close to delivery (&lt;2-4 weeks). Needs prompt removal post-partum and hematology consultation.</li>
</ul>
<h1 id="management-of-vte-peri-partum">Management of VTE Peri-Partum</h1>
<ul>
<li><strong>If the woman is on therapeutic AC:</strong><ul>
<li>Planned delivery<ul>
<li>withhold LMWH for 24 hours pre-neuraxial analgesia</li>
<li>Admit for UFH if VTE diagnosed &lt;4 weeks of delivery, and hold 6 hours pre-neuraxial analgesia</li>
</ul>
</li>
<li>Spontaneous labour --&gt; withhold anticoagulation</li>
</ul>
</li>
<li><strong>If the woman is on prophylactic AC:</strong><ul>
<li>Withhold LMWH anticoagulation 12 hours pre-neuraxial analgesia</li>
</ul>
</li>
<li><strong>Post-partum</strong><ul>
<li>restart AC 4 hours post removal of neuraxial anesthesia</li>
<li>generally this is 4-6 hours post vaginal delivery, 6-8 hours post CS if hemostasis is achieved</li>
</ul>
</li>
</ul>
<h1 id="anticoagulants-and-breast-feeding">Anticoagulants and Breast-Feeding</h1>
<p>Safe in breastfeeding: LMWH, UFH, fondaparinux/danaparoid, warfarin.
Not safe in breastfeeding: DOAC</p>
<p><em>While on anticoagulation, women need to be on contraception (avoid estrogen based contraceptives). This essentially means that they need to consider progestin only pill, Progestin based IUD, or surgical contraception.</em></p>
<div class="admonition note">
<p class="admonition-title">Spontaneous labour</p>
<p>As a rule of thumb, hold anticoagulation for spontaneous labour!</p>
</div>
<h1 id="vte-prophylaxis-in-pregnancy">VTE prophylaxis in pregnancy</h1>
<p><img alt="" src="../_attachments/Pasted%20image%2020230122165851.png" /><img alt="" src="../_attachments/Pasted%20image%2020230122165900.png" /></p>

  <br>
    

    
    
      
    

  <div class="row wm-article-nav-buttons" role="navigation" aria-label="navigation">
    
    <div class="wm-article-nav pull-right">
      <a href="../../Oncology/CAR-T%20Recipients%20in%20the%20ICU/" class="btn btn-xs btn-default pull-right">
        Next
        <i class="fa fa-chevron-right" aria-hidden="true"></i>
      </a>
      <a href="../../Oncology/CAR-T%20Recipients%20in%20the%20ICU/" class="btn btn-xs btn-link">
        CAR T Recipients in the ICU
      </a>
    </div>
    
    <div class="wm-article-nav">
      <a href="../Thyroid%20Disease%20in%20Pregnancy/" class="btn btn-xs btn-default pull-left">
        <i class="fa fa-chevron-left" aria-hidden="true"></i>
        Previous</a><a href="../Thyroid%20Disease%20in%20Pregnancy/" class="btn btn-xs btn-link">
        Thyroid Disease in Pregnancy
      </a>
    </div>
    
  </div>

    <br>
</div>

<footer class="container-fluid wm-page-content">
  <p>Documentation built with <a href="https://www.mkdocs.org/">MkDocs</a> using <a href="https://github.com/gristlabs/mkdocs-windmill">Windmill</a> theme by Grist Labs.</p>
</footer>

</body>
</html>